EDIT Q1 2024 Earnings — Editas Medicine, Inc. Revenue & Financial Results | Market Cap Arena

EDITEditas Medicine, Inc.

$256M

Q1 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1M-88.5% YoY

Gross Profit

-$274,000-24.1% margin

Operating Income

-$67M-5902.3% margin

Net Income

-$62M-5458.1% margin

EPS (Diluted)

$-0.76

QoQ Revenue Growth

-98.1%

Cash Flow

Operating Cash Flow

-$50M

Free Cash Flow

-$52M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$440M

Total Liabilities

$146M

Stockholders' Equity

$294M

Cash & Equivalents

$69M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$10M	-88.5%
Gross Profit	-$274,000	-$28M	+99.0%
Operating Income	-$67M	-$51M	-31.5%
Net Income	-$62M	-$49M	-26.3%